MPR Weekly Dose Podcast Episode 87

This week we have news of the FDA requesting a change to statin prescribing labels, a new vaccine for streptococcus pneumoniae, a new plaque psoriasis cream, a stem cell therapy gets fast tracked as a possible Parkinson disease treatment, and there’s a new treatment approved for Progressive Familial Intrahepatic Cholestasis.

MPR Weekly Dose Podcast Episode 86

This week on the pod we speak about a fact sheet update for the Janssen COVID vaccine. Pfizer and BioNTech are working on a booster version of their vaccine. A supplement is found to contain a prescription ingredient. There’s a new treatment for patients with diabetic kidney disease. And two sunscreen brands are recalled due to the presence of benzene.

MPR Weekly Dose Podcast Episode 85

This week Pfizer recalled their smoking cessation therapy Chantix. A treatment for acute bacterial skin and skin structure infections becomes available. Aduhelm, the newly approved Alzheimer Disease treatment, has its label updated. A blood lead level test is recalled, and there’s updates to the cancer drug Keytruda.

MPR Weekly Dose Podcast 84

The FDA grants Emergency Use to Actemra to treat hospitalized COVID patients. Revisions are been made to the fact sheets for the Moderna and Pfizer BioNTech COVID vaccines to include information related to the risk of myocarditis and pericarditis. A new treatment is approved for some cancer patients allergic to E. coli-Derived asparaginase products. Meanwhile,…

MPR Weekly Dose Podcast 83

This week the FDA approved a first-in-class switch for an antihistamine nasal spray, a new oral contraceptive, and Pradaxa was approved to prevent venous thromboembolism in pediatric patients. Also, we look at a published report on the real-world efficacy of the COVID-19 treatment remdesivir. 

MPR Weekly Dose Podcast 82

This week the FDA approved a regenerative skin tissue therapy and a treatment for advanced mastocytosis, while Novavax’s vaccine for COVID and a novel treatment for MDD show promise, also the FDA issue warning concering hand sanitizers.

MPR Weekly Dose Podcast 81

This week’s episode covers the aducanumab approval. There’s also approvals in treatments for obesity and a first treatment for Plasminogen Deficiency Type 1. Plus, Moderna have sent an EUA request to extend use of their COVID-19 vaccine to those aged 12 and older.

MPR Weekly Dose Podcast 79

This week we have news of changes to the storage of the Pfizer-BioNTech vaccine; A gene therapy gets Fast Track status by the FDA; Vitiligo cream shows promise in clinical trials; And outcomes in atherosclerotic cardiovascular disease are compared for different aspirin dosages.

MPR Weekly Dose Podcast 78

This week we have news of a COVID-19 vaccine authorization expansion for adolescents; A new postoperative pain treatment; There’s a new insulin smart pen devices; Insulin products are recalled; And the FDA grants fast track status to a potential treatment for the rare disease, FSHD.